Insider Trading July 1, 2026 03:12 PM

QNB Corp Director Autumn R Bayles Acquires Additional Shares Under Compensation Plan

Director's purchase increases direct stake as bank completes Victory Bank integration and holds annual meeting

By Sofia Navarro
Share
Twitter Reddit Facebook LinkedIn
QNBC

QNB Corp (NASDAQ:QNBC) director Autumn R Bayles has acquired 219 shares of the company's common stock, bringing her total direct ownership to 3,283.815 shares. The acquisition was part of the company's 2023 Non-Employee Director Compensation Plan and occurred as the stock trades near its 52-week high. Recent corporate developments include the completion of Victory Bank Division integration and the approval of director elections at the 2026 Annual Meeting.

QNB Corp Director Autumn R Bayles Acquires Additional Shares Under Compensation Plan
QNBC
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Director Autumn R Bayles acquired 219 shares valued at $9,603 through the 2023 Non-Employee Director Compensation Plan, increasing her direct ownership to 3,283.815 shares.
  • QNB Corp. completed the systems integration of its Victory Bank Division into QNB Bank, rebranding two branches and two loan production offices under the QNB Bank name.
  • Shareholders approved all proposals at the 2026 Annual Meeting, including the election of four Class II directors, while the Board declared a quarterly cash dividend of $0.39 per share.

Autumn R Bayles, serving as a director at QNB Corp. (NASDAQ:QNBC), has acquired an additional 219 shares of the company's common stock through a transaction executed on July 1, 2026. The acquisition, valued at $9,603, was completed at a per-share price of $43.85. These shares were issued under the terms of QNB Corp.'s 2023 Non-Employee Director Compensation Plan, which governs equity compensation for board members.

Following this transaction, Bayles' direct ownership stake in QNB Corp. common stock has increased to 3,283.815 shares. This total figure includes 58.0434 shares that were acquired through the company's Dividend Reinvestment Plan. The director's purchase comes as QNBC trades near its 52-week high, with the stock delivering a 28% return over the past six months. According to InvestingPro analysis, the stock currently appears overvalued relative to its Fair Value. The company offers a 3.6% dividend yield and has maintained dividend payments for 30 consecutive years, one of several key insights available to InvestingPro subscribers.

In other recent corporate developments, QNB Corp. completed the systems integration of its Victory Bank Division into QNB Bank. This integration involved rebranding two former Victory Bank branches and two loan production offices, which are now operating under the QNB Bank name. Additionally, QNB Corp. held its 2026 Annual Meeting, where shareholders approved all proposals, including the election of four Class II directors: Laurie A. Bergman, Randy S. Bimes, Kenneth F. Brown, Jr., and Randall E. Stauffer. Each director received strong support from the majority of votes cast. Furthermore, the Board of Directors declared a quarterly cash dividend of $0.39 per share, payable on June 26, 2026, to shareholders of record as of June 12, 2026.

These developments highlight QNB Corp.'s ongoing corporate activities and shareholder engagement. The company's stock price data shows a real-time value of 43.90, representing a change of +0.1 (+0.11%). The trading data spans multiple timeframes including 1D, 1W, 1M, 6M, 1Y, 5Y, and Max periods, with values ranging from 43.7 to 44.0 across different intervals.

Risks

  • InvestingPro analysis indicates the stock appears overvalued relative to its Fair Value, suggesting potential valuation risk for investors.
  • The company's 30-year dividend payment history and 3.6% yield may face pressure if interest rate cycles impact banking sector profitability.
  • Integration of Victory Bank Division operations could introduce operational complexities that may affect short-term performance metrics.

More from Insider Trading

X4 Pharmaceuticals CFO David Kirske Sells $36,428 in Common Stock Jul 1, 2026 BillionToOne Executive Sells Shares Under Pre-Arranged Trading Plan Jul 1, 2026 Candel Therapeutics CSO Francesca Barone Executes $235k Share Sale Under Pre-Arranged Plan Jul 1, 2026 Oscar Health CEO Bertolini Executes $35.7 Million Stock Divestiture Amid Market Momentum Jul 1, 2026 Maze Therapeutics Executive Atul Dandekar Executes Pre-Arranged Share Sale and Option Exercise Jul 1, 2026